AstraZeneca_NN
Annual_JJ
Report_NN
and_CC
144_CD
Form_NN
20-F_JJ
Information_NOMZ
2005_CD
NOTES_NN
TO_PIN
THE_DT
FINANCIAL_NN
STATEMENTS_NOMZ
CONTINUED_VBD
7_CD
SHARE_NN
CAPITAL_NN
Allotted_NN
,_,
called-up_JJ
Authorised_NN
and_CC
fully_AMP
paid_VBN
2005 2005 2004_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD [PASS]
Issued_VBN
Ordinary_NN
Shares_NN
$_$
0.25_CD
each_QUAN
395 395 411_CD
Unissued_NN
Ordinary_NN
Shares_NN
$_$
0.25_CD
each_QUAN
205_CD
Redeemable_JJ
Preference_NN
Shares_NN
1_CD
each_QUAN
50,000_CD
600 395 411_CD
The_DT
Redeemable_JJ
Preference_NN
Shares_NN
carry_VPRT
limited_JJ
class_NN
voting_NN
rights_NN
and_CC
no_SYNE
dividend_NN
rights_NN
._.
This_DEMO
class_NN
of_PIN
shares_NN
is_VPRT [BEMA]
capable_PRED
of_PIN
redemption_NOMZ
at_PIN
par_NN
at_PIN
the_DT
option_NOMZ
of_PIN
the_DT
Company_NN
on_PIN
the_DT
giving_VBG
of_PIN
seven_CD
days_NN
written_VBN [PUBV]
notice_NN
to_PIN
the_DT
registered_VBN
holder_NN
of_PIN
the_DT
shares_NN
._.
The_DT
movements_NOMZ
in_PIN
share_NN
capital_NN
during_PIN
the_DT
year_NN
can_POMD
be_VB [PASS]
summarised_VBN
as_IN
follows_VPRT
:_:
No._NN
._.
of_PIN
shares_NN
million_CD
$_$
m_CD [BEMA]
At_PIN
beginning_GER
of_PIN
year_NN
1,645_CD
411_CD
Issues_NN
of_PIN
shares_NN
41_CD
Re-purchase_NN
of_PIN
shares_NN
68_CD
17_CD
At_PIN
31_CD
December_NN
2005_CD
1,581_CD
395_CD
Share_NN
re-purchases_VPRT
During_PIN
the_DT
year_NN
the_DT
Company_NN
re-purchased_JJ
,_,
and_ANDC
subsequently_TIME
canceled_VBN
,_,
67,650,000_CD
Ordinary_NN
Shares_NN
at_PIN
an_DT
average_JJ
price_NN
of_PIN
2445_CD
pence_NN
per_PIN
share_NN
._.
The_DT
total_JJ
consideration_NOMZ
,_,
including_VBG
expenses_NN
,_,
was_VBD
$_$
3,001_CD
m._FW
The_DT
excess_NN
of_PIN
the_DT
consideration_NOMZ
over_IN
the_DT
nominal_JJ
value_NN
has_VPRT [PEAS]
been_VBN [PASS]
charged_VBN
against_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
reserve_NN
._.
Share_NN
schemes_NN
A_DT
total_NN
of_PIN
3,500,109_CD
Ordinary_NN
Shares_NN
were_VBD [PASS]
issued_VBN
during_PIN
the_DT
year_NN
in_PIN
respect_NN
of_PIN
share_NN
schemes_NN
._.
Details_NN
of_PIN
movements_NOMZ
in_PIN
the_DT
number_NN
of_PIN
Ordinary_NN
Shares_NN
under_IN
option_NOMZ
are_VPRT [PASS]
shown_VBN [PRIV]
in_PIN
Note_NN
24_CD
:_:
details_NN
of_PIN
options_NOMZ
granted_VBN [SUAV] [WZPAST]
to_PIN
Directors_NN
are_VPRT [PASS]
shown_VBN [PRIV]
in_PIN
the_DT
Directors_NN
Remuneration_NOMZ
Report_NN
._.
Shares_NN
held_VBN [PRIV] [WZPAST]
by_PIN
subsidiaries_NN
No_SYNE
shares_NN
in_PIN
the_DT
Company_NN
are_VPRT [BYPA]
held_VBN [PRIV]
by_PIN
subsidiaries_NN
._.
8_CD
STATUTORY_NN
AND_PHC
OTHER_NN
INFORMATION_NOMZ
There_EX
are_VPRT
no_SYNE
employees_NN
of_PIN
the_DT
Company_NN
2004_CD
nil_NN
._.
The_DT
directors_NN
of_PIN
the_DT
Company_NN
were_VBD [BYPA]
paid_VBN
by_PIN
another_DT
Group_NN
company_NN
in_PIN
2005_CD
and_CC
2004_CD
._.
The_DT
fee_NN
for_PIN
the_DT
audit_NN
of_PIN
the_DT
Company_NN
is_VPRT
$_$
1,600_CD
2004_CD
$_$
1,600_CD
._.
The_DT
Company_NN
has_VPRT [PEAS]
guaranteed_VBN [PUBV]
the_DT
external_JJ
borrowing_GER
of_PIN
a_DT
subsidiary_NN
,_,
in_PIN
the_DT
amount_NN
of_PIN
$_$
285m_CD
._.
